Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration

Autor(es)

Fonseca-Santos, Bruno ^[1] ; Silva, Patricia Bento ^[2] ; Rigon, Roberta Balasin ^[3] ; Sato, Mariana Rillo ^[1] ; Chorilli, Marius ^[1]

Afiliação do(s) autor(es)

^[1] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Drugs & Med, BR-14801903 Araraquara, SP - Brazil

^[2] Univ Brasilia UnB, Dept Genet & Morphol, BR-70910970 Brasilia, DF - Brazil

^[3] Univ Campinas UNICAMP, Fac Pharmaceut Sci, BR-13083871 Campinas, SP - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: Current Medicinal Chemistry; v. 27, n. 22, p. 3623-3656, 2020.
• Citações Web of Science: 1

Resumo

Colloidal carriers diverge depending on their composition, ability to incorporate drugs and applicability, but the common feature is the small average particle size. Among the carriers with the potential nanostructured drug delivery application there are SLN and NLC. These nanostructured systems consist of complex lipids and highly purified mixtures of glycerides having varying particle size. Also, these systems have shown physical stability, protection capacity of unstable drugs, release control ability, excellent tolerability, possibility of vectorization, and no reported production problems related to large-scale. Several production procedures can be applied to achieve high association efficiency between the bioactive and the carrier, depending on the physicochemical properties of both, as well as on the production procedure applied. The whole set of unique advantages such as enhanced drug loading capacity, prevention of drug expulsion, leads to more flexibility for modulation of drug release and makes Lipid-based nanocarriers (LNCs) versatile delivery system for various routes of administration. The route of administration has a significant impact on the therapeutic outcome of a drug. Thus, the non-invasive routes, which were of minor importance as parts of drug delivery in the past, have assumed added importance drugs, proteins, peptides and biopharmaceuticals drug delivery and these include nasal, buccal, vaginal and transdermal routes. The objective of this paper is to present the state of the art concerning the application of the lipid nanocarriers designated for non-invasive routes of administration. In this manner, this review presents an innovative technological platform to develop nanostructured delivery systems with great versatility of application in non-invasive routes of administration and targeting drug release. (AU)

• Processo FAPESP: 15/05394-2 - Avaliação do potencial de sistemas nanoestruturados baseados em tensoativos para administração nasal de trans-resveratrol na otimização da terapia da Doença de Alzheimer
• Beneficiário: Bruno da Fonseca dos Santos
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 13/09265-7 - Avaliação do potencial de sistemas lipídicos nanoestruturados para administração de compostos de Cu(II) aplicáveis na otimização da terapia da tuberculose
• Beneficiário: Patrícia Bento da Silva
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 14/24180-0 - Sistemas líquido-cristalinos como potencial estratégia para incorporação do trans-resveratrol: desenvolvimento, caracterização físico-química e ensaios biológicos in vitro e in vivo
• Beneficiário: Marlus Chorilli
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/21500-1 - Nanopartículas lipídicas sólidas para incorporação do trans-resveratrol no tratamento tópico do melanoma: avaliação in vitro e in vivo e elucidação dos mecanismos de internalização celular
• Beneficiário: Roberta Balansin Rigon
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 16/11198-4 - Carreadores lipídicos nanoestruturados dispersos em hidrogéis de geleificação in situ para administração vaginal de hipericina associados à terapia fotodinâmica no tratamento da candidíase vulvovaginal
• Beneficiário: Mariana Rillo Sato
• Modalidade de apoio: Bolsas no Brasil - Doutorado